Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.
Tianjin Pharmaceutical Da Ren Tang Dividend Announcement
• Tianjin Pharmaceutical Da Ren Tang announced a annually dividend of $0.03 per ordinary share which will be made payable on 2024-07-12. Ex dividend date: 2024-07-02
• Tianjin Pharmaceutical Da Ren Tang annual dividend for 2024 was $0.03
• Tianjin Pharmaceutical Da Ren Tang annual dividend for 2023 was $0.03
• Tianjin Pharmaceutical Da Ren Tang's trailing twelve-month (TTM) dividend yield is 0.2%
• Tianjin Pharmaceutical Da Ren Tang's payout ratio for the trailing twelve months (TTM) is 2.42%
• Tianjin Pharmaceutical Da Ren Tang's dividend growth over the last five years (2018-2023) was 37.15% year
• Tianjin Pharmaceutical Da Ren Tang's dividend growth over the last ten years (2013-2023) was 6.25% year
Tianjin Pharmaceutical Da Ren Tang Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-02 | $0.03 | annually | 2024-07-12 |
2023-05-26 | $0.03 | annually | 2023-06-06 |
2022-05-24 | $0.02 | annually | 2022-06-02 |
2021-06-15 | $0.01 | annually | 2021-06-24 |
2020-06-15 | $0.01 | annually | 2020-06-24 |
2019-07-01 | $0.01 | annually | 2019-07-15 |
2018-06-28 | $0.01 | annually | 2018-07-13 |
2017-06-28 | $0.00 | annually | 2017-07-14 |
2016-12-05 | $0.00 | annually | |
2016-06-24 | $0.00 | annually | |
2015-05-22 | $0.01 | annually | |
2014-07-04 | $0.01 | annually | |
2013-12-09 | $0.02 | annually |
Tianjin Pharmaceutical Da Ren Tang Dividend per year
Tianjin Pharmaceutical Da Ren Tang Dividend growth
Tianjin Pharmaceutical Da Ren Tang Dividend Yield
Tianjin Pharmaceutical Da Ren Tang current trailing twelve-month (TTM) dividend yield is 0.2%. Interested in purchasing Tianjin Pharmaceutical Da Ren Tang stock? Use our calculator to estimate your expected dividend yield:
Tianjin Pharmaceutical Da Ren Tang Financial Ratios
Tianjin Pharmaceutical Da Ren Tang Dividend FAQ
Other factors to consider when evaluating Tianjin Pharmaceutical Da Ren Tang as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tianjin Pharmaceutical Da Ren Tang stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tianjin Pharmaceutical Da Ren Tang's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tianjin Pharmaceutical Da Ren Tang publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tianjin Pharmaceutical Da Ren Tang distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tianjin Pharmaceutical Da Ren Tang are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tianjin Pharmaceutical Da Ren Tang sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tianjin Pharmaceutical Da Ren Tang distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tianjin Pharmaceutical Da Ren Tang declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tianjin Pharmaceutical Da Ren Tang's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tianjin Pharmaceutical Da Ren Tang's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.